Work

Epidemic waves and cytokine signatures of seven respiratory pathogens after COVID-19 restrictions

Year: 2026
Type: article
Study design: Observational Study
Abstract: Non-pharmaceutical interventions (NPIs) during COVID-19 reduced population exposure to respiratory pathogens, creating population-level immunity debt. After these measures were lifted in China in May 2023, acute respiratory infections resurged with altered age distributions and co-infection dynamics. We conducted 20-month surveillance of 54,902 febrile patients and measured 47 plasma analytes in a nested cohort ( n = 187). Three sequential epidemic waves emerged: SARS-CoV-2 (July–August 2024), influenza A virus (IAV; December 2024–March 2025), and IAV plus human rhinovirus (November 2025–January 2026), with a 9.5% co-infection rate. G-CSF and IL-1Ra were elevated across all pathogens and tracked with clinical severity, whereas IAV-associated IL-4 elevation was severity-independent. A five-cytokine random forest classifier discriminated pathogen groups with 87.3% cross-validated accuracy. Pathogen-characteristic cytokine profiles may support etiological inference from single plasma samples and inform precision-medicine approaches to respiratory infections, pending external validation.
Source: iScience
Language: English
Subfield: Epidemiology
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,240
OpenAlex ID: W7164356782
FWCI:
Cites: 15
Cited by:
Related to: 10